VERA
Vera Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$35.89
+2.57%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$1.61
- Revenue estimate
- $4.3M
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$1.52
- EPS estimate
- -$1.58
- Revenue actual
- —
- Revenue estimate
- $1.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3.8%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $70
- PT range
- $34 – $90
- Analysts
- 5
4 Buy1 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026